Coronary artery disease is the leading cause of mortality in the United States.
However, in the months and years that follow surgery, patients who have
Statin therapy should be prescribed for secondary prevention in patients
Accordingly, the safety and efficacy of monotherapy with these potent agents remains
A previous trial, Randomized Evaluation of Secondary Prevention by
(See "Cardiovascular disease risk assessment for primary prevention
Nevertheless, in the years that follow surgery, CABG patients remain at risk for
Most common types of CVD include coronary artery diseases ( CAD),
Secondary prevention relies on early detection of disease process and
The average follow-up period is 26.75 ± 8.11 months.